The full 43-amino-acid peptide Thymosin beta-4 (Tbeta4, CAS 77591-33-4), a ubiquitous G-actin-sequestering protein present in nearly all human cells. The central actin-binding motif (residues 17-23, LKKTETQ) drives cytoskeletal dynamics, cell motility, and angiogenesis. Evaluated in Phase 2 for venous stasis ulcers, epidermolysis bullosa, and dry-eye disease; studied preclinically for myocardial and soft-tissue repair. Commonly marketed as "TB-500" by research-peptide vendors; not FDA-approved.
For research purposes only. Not medical advice.
NextGen Peptide currently lists TB-500 Thymosin Beta-4 at $3.20/mg, the lowest indexed price across 19 tracked research peptide vendors.
TB-500 Thymosin Beta-4 ranges from $3.20/mg to $12.00/mg across 30 listings from 19 research peptide vendors, normalized to USD per milligram and refreshed daily.
19 research peptide vendors currently list TB-500 Thymosin Beta-4 on PeptideScouter, with 17 in stock right now. We track 30 active listings across size and kit variants.
TB-500 Thymosin Beta-4's CAS Registry Number is 77591-33-4. It is also sold as TB-4 Full Chain, TB-500(TB4), TB-500.